# Alpha Pro Tech Ltd: Form 10-Q for the period ended Jun 30, 2011

- Company: [Alpha Pro Tech Ltd](/companies/apt.md) (CIK 884269)
- Form: 10-Q
- Filed: 2011-08-05
- Accepted by EDGAR: Aug 5, 2011, 11:48 ET
- Period: 2011-06-30
- Accession: 0001437749-11-005505
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/884269/000143774911005505/alphaprotech_10q-063011.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884269/000143774911005505/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-04-01 to 2011-06-30 | $10.3m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2011-01-01 to 2011-06-30 | $19.2m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2011-04-01 to 2011-06-30 | $6.4m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2011-01-01 to 2011-06-30 | $12.1m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2011-04-01 to 2011-06-30 | $3.9m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2011-01-01 to 2011-06-30 | $7.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2011-04-01 to 2011-06-30 | $3.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2011-01-01 to 2011-06-30 | $6.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-04-01 to 2011-06-30 | $369.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2011-01-01 to 2011-06-30 | $17.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2011-04-01 to 2011-06-30 | $181.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2011-01-01 to 2011-06-30 | $115.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-04-01 to 2011-06-30 | $304.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2011-01-01 to 2011-06-30 | $192.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-04-01 to 2011-06-30 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2011-01-01 to 2011-06-30 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-04-01 to 2011-06-30 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2011-01-01 to 2011-06-30 | $0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-04-01 to 2011-06-30 | 22,427,403 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2011-01-01 to 2011-06-30 | 22,431,009 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2011-01-01 to 2011-06-30 | $1.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2011-01-01 to 2011-06-30 | $109.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2011-01-01 to 2011-06-30 | $129.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2011-06-30 | $6.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-06-30 | $31.3m | us-gaap:AssetsCurrent |
| Total assets | at 2011-06-30 | $37.5m | us-gaap:Assets |
| Current liabilities | at 2011-06-30 | $1.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-06-30 | $1.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2011-06-30 | $35.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 39,724 characters.

You should read the following discussion and analysis together with our consolidated financial statements (unaudited) and the notes to our consolidated financial statements (unaudited), which are included elsewhere in this report, and our audited financial statements and the notes thereto, which appear in our Form 10-K for the year ended December 31, 2010.

### SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information set forth in this Form 10-Q contains “forward-looking statements” within the meaning of federal securities laws. Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to potential acquisitions, and other information that is not historical information. When used in this report, the words “estimates”, “expects”, “anticipates”, “forecasts”, “plans”, “intends”, “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. We may make additional forward-looking statements from time to time. All forward-looking statements, whether written or oral and whether made by us or on our behalf, also are expressly qualified by this special note.

Our forward-looking statements are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith, and we believe that there is a reasonable basis for them, including, without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. However, we cannot assure you that management’s expectations, beliefs and projections will result or be achieved or accomplished. Our forward-looking statements apply only as of the date made. Except as required by law, we undertake no obligation to publicly update or revise forward-looking statements that may be made to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Any expectations based on these forward-looking statements are subject to risks and uncertainties and other important factors. Many other factors could affect Alpha Pro Tech Ltd.’s (“Alpha Pro Tech” or the “Company”) future operating results and financial condition and could cause actual results to differ materially from expectations based on forward-looking statements made in this document or elsewhere by Alpha Pro Tech, or on its behalf.

**Where to find more information about us.** We make available, free of charge, on our Internet website (http://www.alphaprotech.com) our most recent Annual Report on Form 10-K, our most recent Quarterly Report on Form 10-Q, any current reports on Form 8-K furnished or filed since our most recent Annual Report on Form 10-K and any amendments to such reports as soon as reasonably practicable following the electronic filing of such report with the Securities and Exchange Commission (“SEC”). In addition, in accordance with SEC rules, we provide electronic or paper copies of our filings free of charge upon request.

### Critical Accounting Policies

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. We base estimates on past experience and on various other assumptions that are believed to be reasonable under the circumstances. The application of these accounting policies on a consistent basis enables us to provide timely and reliable financial information. Our critical accounting polices include the following:

**Inventories:** Inventories include freight-in, materials, labor and overhead costs and are stated at the lower of cost (computed on a standard cost basis, which approximates average cost) or market. Provision is made for slow-moving, obsolete or unusable inventory. We assess our inventory for estimated obsolescence or unmarketable inventory and write down the difference between the cost of inventory and the estimated market value based upon assumptions about future sales and supply on-hand, if necessary. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

**Accounts Receivable:** Accounts receivable are recorded at the invoice amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable; however, changes in circumstances relating to accounts receivable may result in a requirement for additional allowances in the future. The Company determines the allowance based upon historical write-off experience and known conditions about customers’ current ability to pay. Account balances are charged against the allowance after all collection efforts have been exhausted and the potential for recovery is considered remote.

**Revenue Recognition:** For sales transactions, we comply with the provisions of the SEC Staff Accounting Bulletin No. 104, *Revenue Recognition*, which states that revenue should be recognized when the following revenue recognition criteria are met: (1) persuasive evidence of an arrangement exists; (2) title transfers and the customer assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured. These criteria are satisfied upon shipment of product and revenues are recognized accordingly.

**Sales Returns, Rebates and Allowances:** Sales are reduced for any anticipated sales returns, rebates and allowances based on historical experience. Since our return policy is only 90 days and our products are not generally susceptible to external factors such as technological obsolescence or significant changes in demand, we are able to make a reasonable estimate for returns. We offer end-user product specific and sales volume rebates to select distributors. Our rebates are based on actual sales and accrued monthly.

**Stock Based Compensation:** Alpha Pro Tech accounts for stock based awards using FASB ASC 718, *Stock Compensation.* ASC 718 requires companies to record compensation expense for the value of all outstanding and unvested share-based payments, including employee stock options and similar awards.

The fair values of stock option grants are determined using the Black-Scholes-Merton option pricing model and are based on the following assumptions: expected stock price volatility based on historical data and management’s expectations of future volatility, risk-free interest rates from published sources, years to maturity based on historical data and no dividend yield, as management currently does not expect the Company to pay dividends in the near future. The Black-Scholes-Merton option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and that are fully transferable. In addition, the option valuation model requires the input of highly subjective assumptions, including expected stock price volatility. Our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect their fair value.

### OVERVIEW

Alpha Pro Tech is in the business of protecting people, products and environments. We accomplish this by developing, manufacturing and marketing a line of high-value, disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. We also manufacture a line of building supply construction weatherization products. Our products are sold both under the "Alpha Pro Tech" brand name, as well as under private label.

Our products are grouped into three business segments: the Disposable Protective Apparel segment, consisting of disposable protective apparel; the Building Supply segment, consisting of construction weatherization products, such as housewrap and synthetic roof underlayment; and the Infection Control segment, consisting of face masks and eye shields and which previously included a line of medical bed pads and pet beds that was sold during the first quarter of 2011.

Our target markets include pharmaceutical manufacturing, bio-pharmaceutical manufacturing and medical device manufacturing, lab animal research, high technology electronics manufacturing (which includes the semi-conductor market), medical and dental distributors and construction, building supply and roofing distributors.

Our products are used primarily in cleanrooms, industrial safety manufacturing environments and health care facilities, such as hospitals, laboratories and dental offices, as well as building and re-roofing sites. Our products are distributed principally in the United States of America through a network consisting of purchasing groups, national distributors, local distributors, independent sales representatives and our own sales and marketing force.

### RESULTS OF OPERATIONS

The following table sets forth certain operational data as a percentage of sales for the periods indicated:

|  | For the Three Months Ended June 30, 2011 | 2010 | For the Six Months Ended June 30, 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Gross profit | 37.7% | 37.6% | 37.2% | 40.3% |
| Selling, general and administrative expenses | 32.1% | 31.4% | 34.7% | 32.0% |
| Income from operations | 3.6% | 4.3% | 0.0% | 6.5% |
| Income before provision for income taxes | 4.7% | 5.2% | 1.6% | 7.3% |
| Net income | 3.0% | 3.3% | 1.0% | 4.6% |

### Three and Six Months ended June 30, 2011 compared to Three and Six Months ended June 30, 2010

**Sales.** Consolidated sales for the three months ended June 30, 2011 decreased to $10,278,000 from $11,221,000 for the three months ended June 30, 2010, representing a decrease of $943,000, or 8.4%. This decrease consisted of decreased sales in the Disposable Protective Apparel segment of $1,974,000 and decreased sales in the Infection Control segment of $462,000, partially offset by increased sales in the Building Supply segment of $1,493,000.

Sales for the Disposable Protective Apparel segment for the three months ended June 30, 2011 decreased by $1,974,000, or 40.7%, to $2,871,000, compared to $4,845,000 for the same period of 2010. The decrease was primarily due to a decline in sales of disposable protective apparel to our former largest distributor. Although Alpha Pro Tech was informed in the first quarter of 2010 that this distributor had decided to launch its own competing private label line of disposable protective apparel, it was not until the second quarter of 2010 that we started to experience the significant impact of this change. With that said, sales to this distributor in the second quarter of 2010, although down from historical levels, were still significant, as we had orders to fill that were placed before the supply chain change. Sales to this distributor are expected to be insignificant in the coming quarters, as they were only approximately $100,000 for the three months ended June 30, 2011.

Sales to our major international supply chain partner from whom the Company received two awards in 2010 were also down in the second quarter of 2011 as compared to the same quarter of 2010, as a result of significant initial stocking orders to fill their inventory supply for the anticipated increase in business during the second quarter of 2010. Although sales to this partner were down as compared to the same quarter last year, sales in this quarter were higher than the average of the three prior quarters. In addition, this partner’s same quarter sales to its end users were up 39%, demonstrating a strong demand for our products.

Building Supply segment sales for the three months ended June 30, 2011 increased by $1,493,000, or 30.7%, to a quarterly record of $6,356,000, as compared to $4,863,000 for the same period of 2010. We surpassed our previous quarterly record of $5,292,000 by $1,064,000, or 20.1%. The increase was primarily due to a 25.0% increase in sales of REX™ Wrap housewrap and a 32.8% increase in sales of REX™ SynFelt synthetic roof underlayment. The sales mix of the Building Supply segment for the three months ended June 30, 2011 was 69% for synthetic roof underlayment and 31% for housewrap. This compared to 68% for synthetic roof underlayment and 32% for housewrap for the three months ended June 30, 2010.

Our REX™ SynFelt synthetic roof underlayment, we believe, is perceived as an industry leader in terms of quality and that, as the market continues to evolve from felt paper to synthetic roof underlayment, we feel we are in a position to capitalize on significant growth opportunities. REX™ Wrap housewrap, our high-quality, multi-color printed housewrap, we believe, gives us a distinct competitive advantage in the marketplace and as a result, our market share is growing even during the current weak building market and difficult economic environment.

We plan to continue to evolve our product offering. In the fourth quarter of 2010, we launched our new REX™ Wrap Fortis housewrap, our ICC-ES approved non-perforated breathable housewrap. The non-perforated breathable housewrap market accounts for the majority of the total housewrap market, so this new product should increase our housewrap sales and market share. The launch of the REX™ Wrap Fortis housewrap has been slower than anticipated, but the product should start contributing more significantly to the sales line commencing in 2012. We remain optimistic about the future of the Building Supply segment, as our distribution channel strategy continues to strengthen.

Infection Control segment sales for the three months ended June 30, 2011 decreased by $462,000, or 30.5%, to $1,051,000, compared to $1,513,000 for the same period of 2010. Mask sales were down by 38.7%, or $424,000, to $670,000, medical bed pad and pet bed sales were down by $141,000, to $0, as this product line was sold in the first quarter of 2011, and shield sales were up by 37.1%, or $103,000, to $381,000. The overall mask sales decrease for the second quarter of 2011 was primarily due to a decline in industrial mask sales as a result of our previous largest industrial distributor launching its own line of masks as well as a decline in medical and dental mask sales.

Consolidated sales for the six months ended June 30, 2011 decreased to $19,223,000 from $22,850,000 for the six months ended June 30, 2010, representing a decrease of $3,627,000, or 15.9%. This decrease consisted of decreased sales in the Disposable Protective Apparel segment of $4,151,000 and decreased sales in the Infection Control segment of $994,000, partially offset by increased sales in the Building Supply segment of $1,518,000.

Sales for the Disposable Protective Apparel segment for the six months ended June 30, 2011 decreased by $4,151,000, or 41.8%, to $5,778,000, compared to $9,929,000 for the same period of 2010. The decrease was primarily due to a decline in sales of disposable protective apparel to our former largest distributor and to a much lesser extent, reduced sales to regional distributors. The six month decrease was partially offset by a small increase in sales to our major international supply chain partner. The year to date increase to this partner would have been greater had it not been for the large stocking orders in the second quarter of 2010, but sales to this partner’s end users were up 60% year to date, demonstrating a strong demand for our products.

Building Supply segment sales for the six months ended June 30, 2011 increased by $1,518,000, or 15.8%, to $11,103,000, as compared to $9,585,000 for the same period of 2010. The increase was primarily due to a 19.5% increase in sales of REX™ Wrap housewrap and a 13.1% increase in sales of REX™ SynFelt synthetic roof underlayment. The sales mix of the Building Supply segment for the six months ended June 30, 2011 was 68% for synthetic roof underlayment and 32% for housewrap. This compared to 69% for synthetic roof underlayment and 31% for housewrap for the six months ended June 30, 2010.

Infection Control segment sales for the six months ended June 30, 2011 decreased by $994,000, or 29.8%, to $2,342,000, compared to $3,336,000 for the same period of 2010. Mask sales were down by 36.5%, or $866,000, to $1,509,000, medical bed pad and pet bed sales were down by 63.8%, or $176,000, to $101,000, and shield sales were up by 7.0%, or $48,000, to $732,000, all compared to the six months ended June 30, 2010. The overall mask sales decrease for the first six months of 2011 was primarily due to a decline in industrial mask sales as a result of our previous largest industrial distributor launching its own line of masks, as well as a decline in medical and, to a lesser extent, dental mask sales.

On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads. As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill. The net gain on the sale of these assets was $41,000. Both of the transactions were executed in the three months ended March 31, 2011.

**Gross Profit.** Gross profit decreased by $350,000, or 8.3%, to $3,871,000 for the three months ended June 30, 2011 from $4,221,000 for the same period in 2010. The gross profit margin was 37.7% for the three months ended June 30, 2011, compared to 37.6% for the same period of 2010.

Gross profit decreased by $2,066,000, or 22.4%, to $7,144,000 for the six months ended June 30, 2011 from $9,210,000 for the same period in 2010. The gross profit margin was 37.2% for the six months ended June 30, 2011, compared to 40.3% for the same period of 2010.

Gross profit margin for the first six months of 2011 was affected by the change in product mix in which Building Supply segment sales, which have lower margins, increased as a percentage of total sales. Building Supply segment sales comprised a record high 57.8% of total sales for the six months ended June 30, 2011, compared to 41.9% for the same period of 2010. For the first six months of 2011, gross profit margin in the Disposable Protective Apparel segment, although similar to the average of the prior four quarters, was down, as compared to the same period of 2010, due to competitive pricing pressures from our former largest distributor. Management expects gross margin on the Building Supply segment to increase starting in the third quarter, as a price increase went into effect in early July 2011 on Building Supply segment products.

**Selling, General and Administrative Expenses.** Selling, general and administrative expenses decreased by $222,000, or 6.3%, to $3,296,000 for the three months ended June 30, 2011 from $3,518,000 for the three months ended June 30, 2010. As a percentage of net sales, selling, general and administrative expenses increased to 32.1% for the three months ended June 30, 2011 from 31.4% for the same period in 2010.

The decrease of $222,000 in expenses was primarily due to a decrease in employee compensation of $136,000, a decrease of $32,000 in executive bonuses, decreased professional fees and public company expenses of $118,000, decreased travel expenses of $37,000, decreased factory indirect expenses of $23,000 and decreased miscellaneous expenses of $2,000, partially offset by increased commission for the Building Supply segment of $79,000 and increased rent and utilities of $47,000.

The change in expense by segment was as follows: Disposable Protective Apparel was down $76,000, or 9.3%, Infection Control was down $122,000, or 36.7%, and Building Supply was up $140,000, or 14.5%. The remaining change primarily consisted of a $169,000 decrease in corporate unallocated expenses, caused by a decrease in employee compensation and bonuses, professional fees and public company expenses and general office expenses.

Selling, general and administrative expenses decreased by $624,000, or 8.5%, to $6,678,000 for the six months ended June 30, 2011 from $7,302,000 for the six months ended June 30, 2010. As a percentage of net sales, selling, general and administrative expenses increased to 34.7% for the six months ended June 30, 2011 from 32.0% for the same period in 2010.

The decrease of $624,000 in expenses was primarily due to a decrease in employee compensation of $270,000, a decrease of $152,000 in executive bonuses, decreased professional fees and public company expenses of $159,000, decreased travel expenses of $131,000, decreased factory indirect expenses of $74,000, decreased marketing expenses of $59,000 and decreased miscellaneous expenses of $8,000, partially offset by increased rent and utilities of $152,000 and increased commission for the Building Supply segment of $77,000.

The change in expense by segment was as follows: Disposable Protective Apparel was down $299,000, or 16.5%, Infection Control was down $254,000, or 34.3%, and Building Supply was up $278,000, or 13.6%. The remaining change primarily consisted of a $349,000 decrease in corporate unallocated expenses, caused by a decrease in employee compensation, bonuses, and professional fees and public company expenses and general office expenses.

The Company’s Chief Executive Officer and President are each entitled to a bonus equal to 5% of the pre-tax profits of the Company, excluding bonus expense. Bonuses of $34,000 were accrued for the three months ended June 30, 2011, as compared to $66,000 in the same period of 2010. Bonuses of $34,000 were accrued for the six months ended June 30, 2011, as compared to $186,000 in the same period of 2010.

**Depreciation and Amortization.** Depreciation and amortization expense decreased by $12,000, or 5.5%, to $206,000 for the three months ended June 30, 2011 from $218,000 for the same period in 2010. The decrease for the quarter was primarily attributable to decreased depreciation related to the Building Supply segment.

Depreciation and amortization expense increased by $23,000, or 5.4%, to $449,000 for the six months ended June 30, 2011 from $426,000 for the same period in 2010. The increase for the six months was primarily attributable to increased depreciation related to the Disposable Protective Apparel segment.

**Income from Operations.** Income from operations decreased by $116,000, or 23.9%, to $369,000 for the three months ended June 30, 2011, as compared to $485,000 for the three months ended June 30, 2010. The decrease in income from operations was due to a decrease in gross profit of $350,000, partially offset by a decrease in selling, general and administrative expenses of $222,000 and a decrease in depreciation and amortization of $12,000.

Income from operations decreased by $1,465,000, or 98.9%, to $17,000 for the six months ended June 30, 2011, as compared to $1,482,000 for the six months ended June 30, 2010. The decrease in income from operations was due to a decrease in gross profit of $2,066,000 and an increase in depreciation and amortization of $23,000, partially offset by a decrease in selling, general and administrative expenses of $624,000.

**Equity in Income of Unconsolidated Affiliates.** For the three months ended June 30, 2011, we recorded equity in income of unconsolidated affiliates of $107,000, as compared to $99,000 for the same period of 2010. For the six months ended June 30, 2011, we recorded equity in income of unconsolidated affiliates of $234,000, as compared to $172,000 for the same period of 2010.

**Net Gain on Sales of Assets.** On February 8, 2011, the Company entered into an asset purchase agreement to sell its line of pet beds and, on March 30, 2011, entered into a second asset purchase agreement, with the same principal purchaser, to sell its line of medical bed pads. As consideration for the acquired assets, the Company received $235,000, which was comprised of $181,000 of inventory sold at cost, plus an additional $54,000 in compensation for non-inventory assets and goodwill. The net gain from these two transactions was $41,000. In addition, the Company signed a three year non-compete agreement that covers these product lines.

**Income before Provision for Income Taxes.** Income before provision for income taxes for the three months ended June 30, 2011 was $485,000, compared to income before provision for income taxes of $589,000 for the three months ended June 30, 2010, representing a decrease of $104,000, or 17.7%. The decrease in income before provision for income taxes was due primarily to a decrease in income from operations of $116,000, partially offset by an increase of $8,000 in equity in income of unconsolidated affiliates and an increase in net interest income of $4,000.

Income before provision for income taxes for the six months ended June 30, 2011 was $307,000, compared to income before provision for income taxes of $1,669,000 for the six months ended June 30, 2010, representing a decrease of $1,362,000, or 81.6%. The decrease in income before provision for income taxes was due primarily to a decrease in income from operations of $1,465,000, partially offset by an increase of $62,000 in equity in income of unconsolidated affiliates and a net gain on sales of assets of $41,000.

**Provision for Income Taxes.** The provision for income taxes for the three months ended June 30, 2011 was $181,000, compared to provision for income taxes of $217,000 for the same period of 2010. The estimated effective tax rate was 37.3% for the three months ended June 30, 2011, compared to 36.8% for the same period in 2010.

The provision for income taxes for the six months ended June 30, 2011 was $115,000, compared to provision for income taxes of $611,000 for the same period of 2010. The estimated effective tax rate was 37.5% for the six months ended June 30, 2011, compared to 36.6% for the same period in 2010. Management expects the effective tax rate to be in the 37% range going forward.

**Net Income.** Net income for the three months ended June 30, 2011 was $304,000, compared to net income of $372,000 for the three months ended June 30, 2010, a decrease of $68,000, or 18.3%. The net income decrease was primarily due to a decrease in income before provision for income taxes of $104,000, partially offset by a decrease in income taxes of $36,000. Net income as a percentage of sales for the three months ended June 30, 2011 was 3.0%, and net income as a percentage of sales for the same period of 2010 was 3.3%. Basic and diluted income per share for the three months ended June 30, 2011 was $0.01, and basic and diluted income per share for the same period of 2010 was $0.02.

Net income for the six months ended June 30, 2011 was $192,000, compared to net income of $1,058,000 for the six months ended June 30, 2010, a decrease of $866,000, or 81.9%. The net income decrease was primarily due to a decrease in income before provision for income taxes of $1,362,000, partially offset by a decrease in income taxes of $496,000. Net income as a percentage of sales for the six months ended June 30, 2011 was 1.0%, and net income as a percentage of sales for the same period of 2010 was 4.6%. Basic and diluted income per share for the six months ended June 30, 2011 was $0.01, and basic and diluted income per share for the same period of 2010 was $0.05.

### LIQUIDITY AND CAPITAL RESOURCES

As of June 30, 2011, we had cash and cash equivalents of $6,431,000 and working capital of $30,170,000, representing an increase in working capital of 1.1%, or $341,000, since December 31, 2010. As of June 30, 2011, our current ratio was 29:1, compared to 39:1 as of December 31, 2010. Cash and cash equivalents increased by 21.0%, or $1,115,000, to $6,431,000 as of June 30, 2011, compared to $5,316,000 as of December 31, 2010. The increase in cash and cash equivalents was due to cash provided by operating activities of $1,105,000 and cash provided by investing activities of $123,000, partially offset by cash used in financing activities of $113,000.

We have a $3,500,000 credit facility with Wells Fargo Bank, consisting of a line of credit with interest at prime plus 0.5%. As of June 30, 2011, the prime interest rate was 3.25%. This credit line was renewed and expires in May 2012. Our borrowing capacity on the line of credit was $3,500,000 as of June 30, 2011. The available line of credit is based on a formula of eligible accounts receivable and inventories. As of June 30, 2011, we did not have any borrowings under this credit facility.

Net cash provided by operating activities was $1,105,000 for the six months ended June 30, 2011, compared to net cash used in operating activities of $6,326,000 for the six months ended June 30, 2010. The net cash provided by operating activities of $1,105,000 for the six months ended June 30, 2011 was due to net income of $192,000, adjusted by the following: an increase in amortization of share-based compensation expense to $146,000, an increase of depreciation and amortization to $449,000, the gain on the sale of the pet bed and medical bed pad line of $41,000, an increase in equity in income of unconsolidated affiliates to $234,000, an increase in accounts receivable of $1,890,000, a decrease in inventory of $2,017,000, a decrease in prepaid expenses and other current assets of $160,000 and an increase in accounts payable and accrued liabilities of $306,000.

Accounts receivable increased by $1,890,000, or 49.5%, to $5,706,000 as of June 30, 2011 from $3,816,000 as of December 31, 2010. The increase in accounts receivable was primarily related to increased sales in the second quarter of 2011, as compared to the fourth quarter of 2010, as well as strong sales in the latter part of the second quarter of 2011. The number of days of sales outstanding as of June 30, 2011 was 51 days, compared to 33 days as of December 31, 2010. The days of sales outstanding are the expected to be in the 50 day range going forward.

Inventory decreased by $2,198,000, or 12.7%, to $15,120,000 as of June 30, 2011 from $17,318,000 as of December 31, 2010. The decrease was primarily due to a decrease in inventory for the Disposable Protective Apparel segment of $1,492,000, or 22.1%, to $5,267,000 as of June 30, 2011. Inventory for the Infection Control segment decreased by $390,000, or 8.4%, to $4,246,000, primarily due to the sale of the Company’s line of medical bed pads and pet beds. In addition, inventory for the Building Supply segment decreased by $316,000, or 5.3%, to $5,607,000 as of June 30, 2011. From a cash flow perspective, the inventory net change of $2,017,000 is comprised of the balance sheet inventory net change of $2,198,000, less the $181,000 of inventory sold through the sale of the pet bed and medical bed pad lines.

Prepaid expenses and other current assets decreased by $160,000, or 4.3%, to $3,559,000 as of June 30, 2011 from $3,719,000 as of December 31, 2010. The decrease was primarily due to a decrease in prepaid deposits on inventory from Asia.

Accounts payable and accrued liabilities as of June 30, 2011 increased by $306,000, or 39.1%, to $1,089,000 from $783,000 as of December 31, 2010. The change was primarily due to an increase in trade payables of $133,000 and an increase in accrued liabilities of $173,000. Accrued liabilities for the six months ended June 30, 2011 increased as follows: accrued payroll expenses increased by $151,000, rebates and other increased by $6,000 and commission and bonus accrual increased by $42,000, partially offset by a decrease in accrued professional fees of $26,000.

Net cash provided by investing activities was $123,000 for the six months ended June 30, 2011, compared to net cash used in investing activities of $389,000 for the same period of 2010. Our investing activities for the six months ended June 30, 2011 consisted primarily of the cash proceeds from the sale of the pet bed and medical bed pad lines of $235,000, offset by the purchase of property and equipment of $109,000 and the purchase of intangible assets of $3,000, compared to the purchase of property and equipment of $462,000 and the purchase of intangible assets of $4,000 for the same period of 2010. Also in 2010, we received a payment of dividends from our joint venture of $77,000.

Net cash used in financing activities was $113,000 for the six months ended June 30, 2011, compared to net cash provided by financing activities of $6,000 for the same period of 2010. Our net cash used in financing activities for the six months ended June 30, 2011 was due to $129,000 for the repurchase of common stock, partially offset by the proceeds of $16,000 from the exercise of stock options. Our net cash provided by financing activities for the six months ended June 30, 2010 was due to the proceeds from the exercise of stock options.

In February 2010, the Company announced an expansion of $2.0 million to its existing stock repurchase plan. As of June 30, 2011, we had $2,734,000 available for additional stock purchases under our repurchase program. We repurchased 109,763 shares of common stock during the three and six months ended June 30, 2011 at a cost of $129,000. As of June 30, 2011, we had repurchased a total of 6,303,563 shares of common stock at a cost of $7,787,000 through our repurchase program. We retire all stock repurchases upon repurchase. Future repurchases are expected to be funded from cash on hand and cash flows from operations.

We believe that our current cash balance and the funds available under our credit facility will be sufficient to satisfy our projected working capital and planned capital expenditures for the foreseeable future.

### New Accounting Standards

In December 2009, the FASB issued Accounting Standards Update No. 2009-17 (“ASU No. 2009-17”), *Consolidations (Topic 810): Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities.* The amendments in ASU No. 2009-17 replace the quantitative-based risks and rewards calculation for determining which reporting entity, if any, has a controlling financial interest in a variable interest entity with an approach focused on identifying which reporting entity has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity. An approach that is expected to be primarily qualitative will be more effective for identifying which reporting entity has a controlling financial interest in a variable interest entity. The amendments in ASU No. 2009-17 also require additional disclosures about a reporting entity’s involvement in variable interest entities, which will enhance the information provided to users of financial statements. The application of ASU No. 2009-17 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.

In January 2010, the FASB issued Accounting Standards Update No. 2010-06 (“ASU No. 2010-06”), *Improving Disclosures About Fair Value Measurements*. The amendments in ASU No. 2010-06 require separate disclosure of the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and reasons for the transfers and separate presentation of information about purchases, sales, issuances, and settlements in the reconciliation for Level 3 fair value measurements. Additionally, ASU No. 2010-06 clarifies existing disclosures regarding level of disaggregation and inputs and valuation techniques. The new disclosures and clarifications of existing disclosures under ASU No. 2010-06 are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years ending after December 15, 2010 and for interim periods within those fiscal years. The adoption of the disclosure requirements did not have a significant impact on the Company’s consolidated earnings nor the consolidated financial position for the periods presented.

In April 2010, the FASB issued Accounting Standards Update No. 2010-13 (“ASU No. 2010-13”), *Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades – a consensus of the FASB Emerging Issues Task Force.* The amendments in ASU No. 2010-13 address the classification of a share-based payment award with an exercise price denominated in the currency of a market in which the underlying equity security trades. Topic 718 is amended to clarify that a share-based payment award with an exercise price denominated in the currency of a market in which a substantial portion of the entity's equity securities trades shall not be considered to contain a market, performance, or service condition. Therefore, such an award is not to be classified as a liability if it otherwise qualifies as equity classification. The application of ASU No. 2010-13 did not have a significant impact on the consolidated earnings nor the consolidated financial position for the periods presented.

In December 2010, the FASB issued Accounting Standards Update No. 2010-28 (“ASU No. 2010-28), *Intangibles—Goodwill and Other (Topic 350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts*, which modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The amendments in ASU No. 2010-28 are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. Upon adoption of the amendments, any resulting goodwill impairment should be recorded as a cumulative-effect adjustment to beginning retained earnings in the period of adoption. Any goodwill impairments occurring after the initial adoption of the amendments should be included in earnings. The adoption of this guidance did not have a significant impact on the consolidated earnings nor the consolidated financial position of the Company.

We periodically review new accounting standards that are issued. Although some of these accounting standards may be applicable to us, we have not identified any other new standards that we believe merit further discussion, and we expect that none would have a significant impact on our consolidated financial statements.

## Market risk

As filed, 866 characters.

We subcontract the manufacture of products in China and, to a lesser extent, in Mexico, and we have a joint venture in India. In addition, our principal executive office, with 19 employees, is located in Canada. We do not believe that we have a material foreign currency exposure due to the fact that our purchase agreements with companies in China, India and Mexico are settled in U.S. dollars. In addition, all sales transactions are in U.S. dollars. In Canada, our foreign currency exposure is not material due to the fact that we do not conduct manufacturing operations in Canada. Any such exposure is limited to payroll expenses in the Canadian branch office.

We do not expect any significant effect on our consolidated results of operations from inflation or interest or currency rate fluctuations. We do not hedge our interest rate or foreign exchange risks.

## Controls and procedures

As filed, 1,830 characters.

**Evaluation of Disclosure Controls and Procedures.**

Under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act.”)) as of June 30, 2011 pursuant to the evaluation of these controls and procedures required by Rule 13a-15 of the Exchange Act. Disclosure controls and procedures are the controls and other procedures that we have designed to ensure that we record, process, summarize and report in a timely manner the information that we must disclose in reports that we file with or submit to the SEC under the Exchange Act.

In designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and that we are required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation, our principal executive and financial officers concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

### Changes in Internal Control Over Financial Reporting

During the quarter to which this report relates, there was no change in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Filed Aug 5, 2011.
Source: SEC EDGAR, the filing index for accession 0001437749-11-005505. Last ingested by Listed: Nov 10, 2026, 17:48 ET. No prices; not investment advice.
